Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Persistent Medial Knee Pain After TKA
NCT03225092Phase 1Withdrawn
- Sponsor
- The Ohio State University
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of platelet-rich plasma in Pes anserine bursitis (PAB), sponsored by The Ohio State University. Primary endpoint: Knee Society Score at 6 months. Planned start Jul 2017; status: withdrawn.
02
Drugs
platelet-rich plasma
03
Conditions
Pes anserine bursitis (PAB)
Beyond the preview
Go deeper on NCT03225092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03225092.